Starts human trial of zika vaccine
Sinergium Biotech has been investigating a safe immunization against zika virus. It is expected that this year will begin tests in humans, after obtaining good results in mice in the preclinical stage. The zika virus expands throughout the region, and in the summer the countries seek to limit the circulation of the disease, transmitted by the same mosquito as dengue.
Treatment of zika virus almost found
Several scientists in the world have devoted their knowledge and efforts to obtain a medicine or vaccine that can be used in people infected with the zika virus, transmitted by the Aedes aegypti mosquito, which also transmits dengue and chikungunya. The search for a chemical formula triggered laboratory alarms since the World Health Organization (WHO) issued, in early December 2015, an epidemiological alert against zika virus due to its relationship with the increase of newborns with Microcephaly. Since then, many scientific studies have been undertaken worldwide.
Many people infected with Zika virus won’t have symptoms or will only have mild symptoms. The most common symptoms of Zika are: Fever, Rash, Joint pain, Conjunctivitis (red eyes). Other symptoms include: Muscle pain, Headache.
There is no specific medicine or vaccine for Zika virus. Treat the symptoms. Get plenty of rest. Drink fluids to prevent dehydration.Take medicine such as acetaminophen or paracetamol to reduce fever and pain.
What health communicators can learn from Ebola
Since the World Health Organisation declared Zika a global public health emergency in February of this year, much attention has been brought to bear on applying lessons learned during the Ebola crisis of 2014-15.